Skip to main content

Table 3 The impact of early NAI therapy on the clinical outcomes of FluA-CAP patients

From: The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

Variable Patients (n, %) Univariate logistic analysis Multivariate logistic analysis
Early NAI use group (n = 232) Control group (n = 461) OR (95% CI) p-value aaOR (95% CI) p-value
Invasive ventilation 52 (22.4) 106 (23.0) 0.897 (0.612–1.317) 0.577 0.511 (0.312–0.835) 0.007
14-day mortality 32 (13.8) 48 (10.4) 1.377 (0.853–2.221) 0.190 0.477 (0.124–0.744) < 0.001
30-day mortality 60 (25.9) 76 (16.5) 1.767 (1.205–2.592) 0.004 0.533 (0.210–0.807) < 0.001
  1. aAdjusted for weighted propensity scores for treatment, systemic corticosteroid and antibiotic use